Journal
INTERNATIONAL JOURNAL OF HYPERTHERMIA
Volume 22, Issue 3, Pages 241-246Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/02656730600738616
Keywords
solid tumour; tumour pathophysiology; regional therapy; perfusion; TNF; vasoactive drugs
Ask authors/readers for more resources
Solid tumour therapy with chemotherapeutic drugs is hampered by a number of factors resulting in poor results and failure of initially promising drugs. From the application of Tumour Necrosis Factor alpha in the melphalan-based Isolated Limb perfusion some lessons could be learned. Most importantly, combination of treatment approaches, certainly when multiple targets are involved, increases the effectiveness of the therapy. Clinical outcome may improve dramatically when the tumour pathophysiology is changed in such a way that co-administered chemotherapeutics are more active or are capable of reaching the tumour cells better. Here some of the methodologies and drug combinations which improve solid tumour therapy through acting on the tumour pathophysiology are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available